Trius Therapeutics Inc 4
4 · Trius Therapeutics Inc · Filed Jun 11, 2013
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-06-11$8.94/sh−1,000$8,940→ 180,860 total(indirect: By Trust)
Holdings
- 2,151
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
- [F2]Includes 369 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.